JNJ-17203212
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
821768-06-3
C04460-5mg
JNJ-17203212 is a selective, potent and competitive TRPV1 antagonist. JNJ-17203212 is developed for researching pain management, such as migraine.
3 years-20°C powder 2 years-80°C in solvent
Beschrijving
JNJ-17203212 Beschikbaar in 5 mg. Wordt geleverd met droogijs. Bestel eenvoudig online met snelle levering.
Specificaties
Recent bekeken producten
MEM Amino Acids Solution (50x) w/o: L-Glutamine
P08-30100
100 mL
White glass slide, frosted
1380-20
1440/CS
Anti-TNF-α (Adalimumab), humanized Antibody
A1048-100
100 µg
PEPTIC DIGEST OF ANIMAL TISSUE (MEAT PEPTONE)
P16-102-01
500 g
GelRed® Agarose LE
#41029-5G
1x 5 g
HT115 (DE3) Super Competent Cells
D1045S
10x 100 μL
HT115
ACC-130
10 Tubes
Rat Reticulon-4 receptor, RTN4R ELISA Kit
MBS9325746-01
48 Well
Recent gezochte producten
Amino Acids Solution 100X, Sterile
40120716-4
1 L
Amino Acids Solution 100X, Sterile
40120716-2
250 mL
MEM Non-Essential Amino Acids Solution (100X)
HY-K3011-01
100 mL
Amino Acids Solution 100X, Sterile
40120716-1
100 mL
Amino Acids Solution 100X, Sterile
40120716-3
500 mL
Amino Acids Solution 100X, Sterile
40120716-2
250 mL
Amino Acids Solution 100X, Sterile
40120716-4
1 L
MEM Amino Acids Solution (50x) w/o: L-Glutamine
P08-30100
100 mL